Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.

Hans-Juergen Reulen; Gabriele Poepperl; Claudia Goetz; Franz Joseph Gildehaus; Michael Schmidt; Klaus Tatsch; Torsten Pietsch; Theo Kraus; Walter Rachinger

doi:10.3171/2014.12.JNS142168

Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.

Hans-Juergen Reulen, Gabriele Poepperl, Claudia Goetz, Franz Joseph Gildehaus, Michael Schmidt, Klaus Tatsch, Torsten Pietsch, Theo Kraus, Walter Rachinger

Institute of Pathology

Research output: Contribution to journal › Original Article › peer-review

24 Citations (Web of Science)

Original language	English
Pages (from-to)	76-70
Journal	JOURNAL OF NEUROSURGERY
Volume	123
Issue number	3
DOIs	https://doi.org/10.3171/2014.12.JNS142168
Publication status	Published - 2015

Keywords

RECURSIVE PARTITIONING ANALYSIS
CREATED RESECTION CAVITIES
MONOCLONAL-ANTIBODY 81C6
MALIGNANT GLIOMA
LOCOREGIONAL RADIOIMMUNOTHERAPY
GLIOBLASTOMA-MULTIFORME
PHASE-III
TENASCIN
BRAIN
TRIAL

Access to Document

10.3171/2014.12.JNS142168

Cite this

Reulen, H.-J., Poepperl, G., Goetz, C., Gildehaus, F. J., Schmidt, M., Tatsch, K., Pietsch, T., Kraus, T., & Rachinger, W. (2015). Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. JOURNAL OF NEUROSURGERY , 123(3), 76-70. https://doi.org/10.3171/2014.12.JNS142168

Reulen, Hans-Juergen ; Poepperl, Gabriele ; Goetz, Claudia et al. / Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. In: JOURNAL OF NEUROSURGERY 2015 ; Vol. 123, No. 3. pp. 76-70.

@article{7673adb90b2f4b368d6ed7b309d635a9,

title = "Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.",

keywords = "RECURSIVE PARTITIONING ANALYSIS, CREATED RESECTION CAVITIES, MONOCLONAL-ANTIBODY 81C6, MALIGNANT GLIOMA, LOCOREGIONAL RADIOIMMUNOTHERAPY, GLIOBLASTOMA-MULTIFORME, PHASE-III, TENASCIN, BRAIN, TRIAL",

author = "Hans-Juergen Reulen and Gabriele Poepperl and Claudia Goetz and Gildehaus, {Franz Joseph} and Michael Schmidt and Klaus Tatsch and Torsten Pietsch and Theo Kraus and Walter Rachinger",

year = "2015",

doi = "10.3171/2014.12.JNS142168",

language = "English",

volume = "123",

pages = "76--70",

journal = "JOURNAL OF NEUROSURGERY ",

issn = "0022-3085",

publisher = "Amer Assoc Neurological Surgeons",

number = "3",

}

Reulen, H-J, Poepperl, G, Goetz, C, Gildehaus, FJ, Schmidt, M, Tatsch, K, Pietsch, T, Kraus, T & Rachinger, W 2015, 'Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.', JOURNAL OF NEUROSURGERY , vol. 123, no. 3, pp. 76-70. https://doi.org/10.3171/2014.12.JNS142168

Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. / Reulen, Hans-Juergen; Poepperl, Gabriele; Goetz, Claudia et al.
In: JOURNAL OF NEUROSURGERY , Vol. 123, No. 3, 2015, p. 76-70.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.

AU - Reulen, Hans-Juergen

AU - Poepperl, Gabriele

AU - Goetz, Claudia

AU - Gildehaus, Franz Joseph

AU - Schmidt, Michael

AU - Tatsch, Klaus

AU - Pietsch, Torsten

AU - Kraus, Theo

AU - Rachinger, Walter

PY - 2015

Y1 - 2015

KW - RECURSIVE PARTITIONING ANALYSIS

KW - CREATED RESECTION CAVITIES

KW - MONOCLONAL-ANTIBODY 81C6

KW - MALIGNANT GLIOMA

KW - LOCOREGIONAL RADIOIMMUNOTHERAPY

KW - GLIOBLASTOMA-MULTIFORME

KW - PHASE-III

KW - TENASCIN

KW - BRAIN

KW - TRIAL

U2 - 10.3171/2014.12.JNS142168

DO - 10.3171/2014.12.JNS142168

M3 - Original Article

C2 - 26140493

SN - 0022-3085

VL - 123

SP - 76

EP - 70

JO - JOURNAL OF NEUROSURGERY

JF - JOURNAL OF NEUROSURGERY

IS - 3

ER -

Reulen HJ, Poepperl G, Goetz C, Gildehaus FJ, Schmidt M, Tatsch K et al. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. JOURNAL OF NEUROSURGERY . 2015;123(3):76-70. doi: 10.3171/2014.12.JNS142168